Vistagen (VTGN) announced the appointment of Nick Tressler as CFO, effective immediately. Most recently, he served as CFO of Dynex Technologies.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTGN:
- Vistagen presents exploratory PH80 data at Menopause Society meeting
- VistaGen Therapeutics: Buy Rating Backed by Promising Clinical Trials and Stable Financial Outlook
- Vistagen Therapeutics’ Earnings Call Highlights Progress and Challenges
- Vistagen Therapeutics Reports Q2 2026 Financial Results
- VistaGen Therapeutics: Buy Rating Affirmed Amid Promising Fasedienol Trials and Market Potential